Clinical Drug Investigation

Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone: A Randomized, Three-Phase, Crossover, Placebo-Controlled Study
pp. 143-153(11)
Authors: Grönlund, Juha; Saari, Teijo I.; Hagelberg, Nora M.; Neuvonen, Pertti J.; Laine, Kari; Olkkola, Klaus T.

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers: A Randomized, Open-Label, Two-Period, Parallel-Group, Crossover Study
pp. 155-167(13)
Authors: Nichols, Alice I.; Focht, Kristen; Jiang, Qin; Preskorn, Sheldon H.; Kane, Cecelia P.

Effects of Nilotinib on Single-Dose Warfarin Pharmacokinetics and Pharmacodynamics: A Randomized, Single-Blind, Two-Period Crossover Study in Healthy Subjects
pp. 169-179(11)
Authors: Yin, Ophelia Q.P.; Gallagher, Neil; Fischer, Deirdre; Zhao, Lily; Zhou, Wei; Leroy, Elisabeth; Golor, Georg; Schran, Horst

Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting: A Randomized, Open-Label Study
pp. 181-189(9)
Authors: Ekesbo, Rickard; Sjöstedt, Svante; Sörngård, Heléne

Importance of C-Reactive Protein Level in Predicting Non-Response to Additional Intravenous Immunoglobulin Treatment in Children with Kawasaki Disease: A Retrospective Study
pp. 191-199(9)
Authors: Iwashima, Satoru; Kimura, Mituaki; Ishikawa, Takamichi; Ohzeki, Takehiko

Effects of Manidipine and its Combination with an ACE Inhibitor on Insulin Sensitivity and Metabolic, Inflammatory and Prothrombotic Markers in Hypertensive Patients with Metabolic Syndrome: The MARCADOR Study
pp. 201-212(12)
Authors: Martinez-Martin, Francisco J.; Macias-Batista, Alicia; Comi-Diaz, Cristina; Rodriguez-Rosas, Herminia; Soriano-Perera, Paula; Pedrianes-Martin, Pablo